Discovery of ((4-(5-(Cyclopropylcarbamoyl)-2-methylphenylamino)-5-methylpyrrolo[1,2-f][1,2,4]triazine-6-carbonyl)(propyl)carbamoyloxy)methyl-2-(4-(phosphonooxy)phenyl)acetate (BMS-751324), a Clinical Prodrug of p38α MAP Kinase Inhibitor

  • Chunjian Liu
  • , James Lin
  • , John Hynes
  • , Hong Wu
  • , Stephen T. Wrobleski
  • , Shuqun Lin
  • , T. G.Murali Dhar
  • , Vivekananda M. Vrudhula
  • , Jung Hui Sun
  • , Sam Chao
  • , Rulin Zhao
  • , Bei Wang
  • , Bang Chi Chen
  • , Gerry Everlof
  • , Christoph Gesenberg
  • , Hongjian Zhang
  • , Punit H. Marathe
  • , Kim W. McIntyre
  • , Tracy L. Taylor
  • , Kathleen Gillooly
    • David J. Shuster, Murray McKinnon, John H. Dodd, Joel C. Barrish, Gary L. Schieven, Katerina Leftheris

Research output: Contribution to journal › Article › peer-review

11   Link opens in a new tab Scopus citations

Fingerprint

Dive into the research topics of 'Discovery of ((4-(5-(Cyclopropylcarbamoyl)-2-methylphenylamino)-5-methylpyrrolo[1,2-f][1,2,4]triazine-6-carbonyl)(propyl)carbamoyloxy)methyl-2-(4-(phosphonooxy)phenyl)acetate (BMS-751324), a Clinical Prodrug of p38α MAP Kinase Inhibitor'. Together they form a unique fingerprint.
Sort by

Keyphrases

Pharmacology, Toxicology and Pharmaceutical Science